Form 4: Galecto, Inc. Director David Shapiro Receives Stock Option Grant

Director David Shapiro was granted a stock option to purchase 18,000 shares of Galecto, Inc. common stock at an exercise price of $0.49 per share on June 20, 2024.

Summary

• David Shapiro, a director of Galecto, Inc., received a stock option grant on June 20, 2024.
• The option allows Shapiro to purchase 18,000 shares of Galecto's common stock at an exercise price of $0.49 per share.
• The option was granted automatically under the Issuer's Non-Employee Director Compensation Policy on the date of the Issuer's 2024 Annual Meeting of Stockholders.
• The shares subject to the option vest in equal monthly installments until the first anniversary of the grant date.
• The option expires on June 19, 2034.

Sentiment

Score: 7

Explanation: Routine director compensation; positive in that it aligns interests, but not a major event.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service on the board.

Industry Context

Stock options are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing them to increase company value.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the biotechnology industry depending on company size, stage of development, and board composition.
• Comparing Galecto's director compensation to peers like Genmab or Argenx would provide a better understanding of whether this grant is within industry norms.
• Factors such as the vesting schedule and exercise price are also important when benchmarking against industry standards.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the director's actions lead to improved company performance.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock option, director compensation, Form 4, Galecto, GLTO, David Shapiro, insider transaction